Further mechanisms such as epigenetic changes within tumor cells and mutations in DAXX (death-domain-associated protein) or ATRX (alpha thalassemia/mental retardation syndrome X-linked) have also been proposed (Angelousi et al. 2023). The gene discussed is DAXX; the disease is alpha thalassemia spectrum.